SIRT2 has pro-cancer effects in numerous cancers, including breast, lung, gastric, liver, pancreatic, and colorectal cancers, where it induces tumor development mainly by altering the tumor microenvironment, inducing immune evasion, and regulating energy metabolism 182. The gene discussed is SIRT2; the disease is cancer.